A Lishchinskaya

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Prevention of venous thromboembolic complications in patients with ulcerative colitis

Prevention of venous thromboembolic complications in patients with ulcerative colitis

Journal: Terapevticheskii arkhiv

Published: September 21, 2024

Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases

Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases

Journal: Terapevticheskii arkhiv

Published: March 28, 2022

Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy

Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy

Journal: Terapevticheskii arkhiv

Published: January 14, 2022

Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn's disease when switching from the original infliximab to its biosimilars

Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn's disease when switching from the original infliximab to its biosimilars

Journal: Terapevticheskii arkhiv

Published: February 15, 2021

Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation

Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation

Journal: Terapevticheskii arkhiv

Published: April 16, 2020

Stem Cell Therapy for Perianal Crohn's Disease.

Stem Cell Therapy for Perianal Crohn's Disease.

Journal: Terapevticheskii arkhiv

Published: February 01, 2019

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice.

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice.

Journal: Terapevticheskii arkhiv

Published: February 01, 2019

Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy.

Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy.

Journal: Terapevticheskii arkhiv

Published: February 01, 2019

Efficacy of adalimumab for Crohn's disease in real clinical practice

Efficacy of adalimumab for Crohn's disease in real clinical practice

Journal: Terapevticheskii arkhiv

Published: March 11, 2017

Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: results of a 5-year follow-up

Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: results of a 5-year follow-up

Journal: Terapevticheskii arkhiv

Published: April 14, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026